MAPS to bring German Medical Affairs leaders to Munich for October forum

German Medical Affairs leaders will meet in Munich on Oct. 6, 2026, for a peer-led MAPS forum focused on 2027 leadership priorities, evidence readiness, GenAI governance and medical-commercial collaboration. The working session is designed to help affiliates address Germany’s regulatory and operational pressures with practical, non-promotional solutions.

Why it matters: - German Medical Affairs teams are facing tighter pressure from AMNOG, G-BA, EU HTA, digital governance and cross-functional execution. - The forum is built to help leaders move from broad discussion to workable plans for 2027 and beyond. - The event targets practical issues that affect evidence generation, governance and affiliate decision-making in Germany.

What happened: - MAPS will host the MAPS Germany Medical Affairs Leadership Forum in Munich on Oct. 6, 2026. - The event is a senior, peer-led working session for German Medical Affairs leaders. - The forum was developed with German Country Medical Directors and affiliate leaders. - Organizers said the program reflects the operational realities of the German market rather than generic regional content.

The details: - The forum will focus on four priority areas identified by German CMDs: CMD leadership priorities for 2027; evidence readiness under Germany’s AMNOG, G-BA and EU HTA frameworks; GenAI governance for Medical Affairs; and medical-commercial boundaries, including decision rights, documentation and compliant collaboration. - The format will include peer-led roundtables, scenario-based discussion and facilitated exchange. - The session is designed to be non-promotional and compliance-aware. - The target audience includes Country Medical Directors, affiliate Medical Affairs heads, medical strategy and operations leaders, field medical leaders, evidence generation and HEOR leaders, launch readiness leaders, and digital, governance, compliance and transformation leaders. - Event details: Oct. 6, 2026; 9:00 AM to 5:00 PM Germany time; Andaz Munich Schwabinger Tor, Leopoldstraße 170, 80804 Munich, Germany. - Registration is open to members and non-members. - Pricing is $249 for MAPS members and $299 for non-members. - MAPS is inviting recommendations for senior German Medical Affairs leaders and selected functional experts to contribute to the discussion. - Interested contributors should bring senior perspective, Germany relevance and practical experience in leadership, evidence readiness, GenAI governance, affiliate execution or medical-commercial collaboration. - Prospective contributors should contact Daniel Moore, Director of Strategic Operations, EMEA + APAC.

Between the lines: - MAPS is positioning the forum as a working session, not a standard conference. - That approach signals demand for peer benchmarking and operational guidance over high-level presentations. - The emphasis on GenAI governance suggests AI adoption in Medical Affairs is moving into a compliance and operating-model phase. - The focus on medical-commercial boundaries points to continued sensitivity around collaboration and documentation inside German affiliates.

What's next: - MAPS will continue shaping the program with input from senior German Medical Affairs leaders and functional experts. - Registration remains open ahead of the Oct. 6 forum. - Selected contributors may be added to the discussion based on relevance and practical experience. - More information is available through MAPS at MedicalAffairs.org. - MAPS also maintains a LinkedIn presence at its social media page.

The bottom line: - The Munich forum is designed to give German Medical Affairs leaders a practical, compliance-aware space to prepare for 2027 priorities and growing operational complexity.